KRYS Krystal Biotech, Inc.
Stock Price & Overview

$147.49-2.66 (-1.77%)4:00 PM 07/18/25
NASDAQ | $USD | Post-Market: $146.00 -1.49 (-1.01%) 7:50 PM

Valuation Metrics

KRYS Valuation Grade

Type
Grade
KRYS
Sector Median
% Diff. to Sector
KRYS 5Y Avg.
% Diff. to 5Y Avg.
P/E Non-GAAP (TTM)
-Rating: Not Covered
-
16.29
-
-
-
P/E Non-GAAP (FWD)
-Rating: Not Covered
-
17.03
-
-
-
P/E GAAP (TTM)
35.49
26.22
35.34%
-
NM
P/E GAAP (FWD)
27.46
23.31
17.79%
-
NM
PEG GAAP (TTM)
0.33
0.74
-56.04%
-
NM
PEG Non-GAAP (FWD)
-
1.77
-
-
-
EV / Sales (TTM)
10.52
3.30
219.05%
-
NM
EV / Sales (FWD)
8.75
3.15
177.76%
-
NM
EV / EBITDA (TTM)
25.80
13.73
87.89%
-
NM
EV / EBITDA (FWD)
20.07
11.85
69.35%
-
NM
EV / EBIT (TTM)
26.26
19.56
34.24%
-
NM
EV / EBIT (FWD)
21.80
14.84
46.84%
-
NM
Price / Sales (TTM)
12.70
3.39
275.20%
-
NM
Price / Sales (FWD)
10.64
3.51
203.24%
-
NM
Price / Book (TTM)
4.33
2.39
81.01%
4.33
-0.06%
Price / Book (FWD)
-
2.64
-
-
-
Price / Cash Flow (TTM)
30.77
14.97
105.63%
-
NM
Price / Cash Flow (FWD)
22.47
13.52
66.22%
-
NM
Dividend Yield (TTM)
-
1.78%
-
-
-

Go Premium to see Valuation Grades on KRYS

*Grades are relative to the Health Care sector

**NM signifies a non meaningful value. A dash signifies the data is not available.

KRYS Price/Earnings (P/E) Ratio

View Krystal Biotech, Inc. (KRYS) current and estimated P/E ratio data provided by Seeking Alpha.

Price/Earnings Ratio

Consensus EPS Estimate Growth Rate

Capital Structure